Online citations, reference lists, and bibliographies.
← Back to Search

Development Of Poly (dialkyl Methylidenemalonate) Nanoparticles As Drug Carriers

T.K.M. T.K.M. Mbela, J. Poupaert, P. Dumont, A. Haemers
Published 1993 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Two novel dialkylmethylidenemalonate (DAMM) analogs: diallylmethylidenemalonate (AAMM, 1b) and cyclohexylethylmethylidenemalonate (CEMM, 1c) were synthesized and evaluated for their capacity to polymerise to stable nanoparticles and to adsorb primaquine diphosphate (PQ). PQ loading onto poly-AAMM (PAAMM, 1b) and poly-CEMM (PCEMM, 1c) was up to 90% in the pH range from 6.0 to 8.5. A significant improvement of the physicochemical characteristics and the PQ desorption capacity of the nanoparticles was achieved in this series of PDAMM analogs.
This paper references
10.1016/0021-9797(85)90087-6
Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers
S. J. Douglas (1985)
10.1002/JPS.2600651115
In vitro studies of poly(methyl methacrylate) adjuvants.
J. Kreuter (1976)
10.1016/0021-9797(84)90015-8
Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles: I. Influence of physicochemical factors
S. J. Douglas (1984)
10.1016/0378-5173(92)90090-O
Poly(diethylmethylidene Malonate) Nanoparticles As Primaquine Delivery System To Liver
T. Mbela (1992)
10.1016/0168-3659(90)90013-J
Nanocapsules as carriers for oral peptide delivery
C. Damgé (1990)
10.1002/POL.1977.130150703
Ionic and zwitterionic polymerization of n-alkyl 2-cyanoacrylates
E. Donnelly (1977)
10.1016/0378-5173(91)90133-9
Nanoparticles of Polyisohexylcyanoacrylate (pihca) As Carriers of Primaquine - Formulation, Physicochemical Characterization and Acute Toxicity
R. Gaspar (1991)
10.1016/0014-5793(87)80513-6
Photooxidation products of primaquine Structure, antimalarial activity and hemolytic effects
A. Brossi (1987)
10.1002/JPS.2600710717
Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.
P. Couvreur (1982)
10.1002/JPS.2600781215
New method for the preparation of cyanoacrylic nanoparticles with improved colloidal properties.
V. Lenaerts (1989)
10.1016/0378-5173(91)90172-K
Adsorption of hematoporphyrin onto polyalkylcyanoacrylate nanoparticles: carrier capacity and drug release
N. Brasseur (1991)
10.1002/JPS.2600651217
Polymerized micelles and their use as adjuvants in immunology.
G. Birrenbach (1976)
10.1016/0378-5173(90)90123-L
Polymeric and emulsion carriers—interaction with antiflocculants and ionic surfactants
J. S. Lucks (1990)
10.3109/02652048809056475
Possibilities of using nanoparticles as carriers for drugs and vaccines.
J. Kreuter (1988)
10.1002/JPS.2600800117
Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice.
J. De Keyser (1991)
10.1016/0021-9797(85)90049-9
A simple turbidimetric method for the determination of the refractive index of large colloidal particles applied to casein micelles
M. C. Griffin (1985)
10.1002/JPS.2600750408
Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules.
J. Rollot (1986)
10.1002/JPS.2600730730
In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells.
V. Lenaerts (1984)
Liposomes as drug carriers : recent trends and progress
G. Gregoriadis (1988)
10.1016/0378-5173(87)90080-9
Attachment of antibiotics to nanoparticles: preparation, drug-release and antimicrobial activity in vitro
S. Henry-Michelland (1987)
Selected Methods in Cellular Immunology
B. B. Mishell (1980)
Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice.
A. Gabizon (1982)
10.1016/0169-409X(89)90029-X
Liposomes in cancer therapy
S. Daoud (1989)
10.1016/0378-5173(90)90024-X
Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading
B. Seijo (1990)



This paper is referenced by
10.1016/J.EJPB.2007.08.003
Biocompatible poly(methylidene malonate)-made materials for pharmaceutical and biomedical applications.
P. Breton (2008)
Verwendung von methylenmalondiesterderivaten zur herstellung von gashaltigen mikropartikeln für die ultraschalldiagnostik, sowie diese partikel enthaltende mittel
C. Albayrak (1996)
10.1016/S0169-409X(00)00116-2
Nanoparticulate systems for the delivery of antisense oligonucleotides.
G. Lambert (2001)
10.1081/DDC-120014584
A Study on the Preparation and Anti-Tumor Efficacy of Bovine Serum Albumin Nanospheres Containing 5-Fluorouracil
K. Santhi (2002)
10.1007/978-0-387-77668-2_21
Nanopharmaceuticals: Challenges and Regulatory Perspective
R. Shah (2009)
10.1006/JCIS.1999.6381
Aluminum Polyphosphate Nanoparticles: Preparation, Particle Size Determination, and Microchemistry.
do Rego Monteiro VA (1999)
10.2174/1874123101004010042
Carotenoid Pigments Encapsulation: Fundamentals, Techniques andRecent Trends
D. T. Santos (2014)
10.1007/978-1-4614-0881-9_10
Targeted Delivery Using Biodegradable Polymeric Nanoparticles
E. Fattal (2012)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
ENCAPSULATION TECHNIQUES BASED ON PHYSICAL NATURE COMBINATION BETWEEN COATING MATERIAL AND CORE MATERIAL
D. T. Santos (2010)
10.1007/978-1-4614-0881-9
Fundamentals and Applications of Controlled Release Drug Delivery
J. Siepmann (2012)
10.1002/0471264180.OR052.01
The Retro–Diels–Alder Reaction Part I. C ? C Dienophiles
B. Rickborn (2004)
PLGA- and PLA-Based Polymeric Nanoparticles for Antimicrobial Drug Delivery
Soosan Abdollahi (2015)
10.2174/2211738511301010035
Primaquine Loaded Chitosan Nanoparticles For Liver Targeting
N. Gupta (2012)
Semantic Scholar Logo Some data provided by SemanticScholar